Management of Group B streptococcal sepsis risk in well, term newborns
Authors:
- 24 August 2011
- journal article
- research article
- Published by Wiley in Acta Paediatrica
- Vol. 101 (2) , 128-131
Abstract
Aim: To investigate how clinically well, term newborns at risk of early-onset Group B streptococcal (EOGBS) disease are currently managed in the United Kingdom (UK). Methods: Review of guidelines of UK neonatal units. Results: One hundred and twenty-five guidelines covering 157 neonatal units were received (71% of UK units), three of which were excluded from the review. We found great variation in every aspect for the management of EOGBS disease risk including the following: definition of risk factors; management of at-risk newborns; choice of antibiotics. Conclusion: Our findings highlight the need for national consensus guidelines and clinical trials into the management of risk babies at risk of EOGBS disease.Keywords
This publication has 7 references indexed in Scilit:
- Neonatal infections in England: the NeonIN surveillance networkArchives of Disease in Childhood - Fetal and Neonatal Edition, 2010
- Group B streptococcal disease in infants: a case control studyArchives of Disease in Childhood, 2009
- The Local Adaptation of National Recommendations for Preventing Early-Onset Neonatal Group B Streptococcal Disease in Uk Maternity UnitsJournal of Health Services Research & Policy, 2008
- Antenatal screening and intrapartum management of Group B Streptococcus in the UKBJOG: An International Journal of Obstetrics & Gynaecology, 2004
- Group B streptococcal disease in UK and Irish infants younger than 90 daysThe Lancet, 2004
- Early-Onset Group B Streptococcal Infection After a Combined Maternal and Neonatal Group B Streptococcal Chemoprophylaxis StrategyPediatrics, 2003
- Prevention of Early-Onset Neonatal Group B Streptococcal Disease with Selective Intrapartum ChemoprophylaxisNew England Journal of Medicine, 1986